89bio, Inc. (ETNB)

NASDAQ: ETNB · IEX Real-Time Price · USD
11.31
+0.11 (0.98%)
At close: Mar 27, 2024, 4:00 PM
11.35
+0.04 (0.35%)
After-hours: Mar 27, 2024, 5:20 PM EDT

Total Valuation

89bio has a market cap or net worth of $1.06 billion. The enterprise value is $506.66 million.

Market Cap 1.06B
Enterprise Value 506.66M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

89bio has 93.50 million shares outstanding. The number of shares has increased by 104.48% in one year.

Shares Outstanding 93.50M
Shares Change (YoY) +104.48%
Shares Change (QoQ) +5.85%
Owned by Insiders (%) 0.89%
Owned by Institutions (%) 106.41%
Float 69.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.97
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.04, with a Debt / Equity ratio of 0.05.

Current Ratio 20.04
Quick Ratio n/a
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -27.85

Financial Efficiency

Return on equity (ROE) is -31.00% and return on invested capital (ROIC) is -26.84%.

Return on Equity (ROE) -31.00%
Return on Assets (ROA) -27.80%
Return on Capital (ROIC) -26.84%
Revenue Per Employee n/a
Profits Per Employee -$2.03M
Employee Count 70
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, 89bio has paid $3.87 million in taxes.

Income Tax 3.87M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.83% in the last 52 weeks. The beta is 0.95, so 89bio's price volatility has been similar to the market average.

Beta (1Y) 0.95
52-Week Price Change -30.83%
50-Day Moving Average 11.00
200-Day Moving Average 12.88
Relative Strength Index (RSI) 46.71
Average Volume (30 Days) 1,368,095

Short Selling Information

The latest short interest is 11.11 million, so 11.88% of the outstanding shares have been sold short.

Short Interest 11.11M
Short Previous Month 10.86M
Short % of Shares Out 11.88%
Short % of Float 15.99%
Short Ratio (days to cover) 7.98

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -151.20M
Pretax Income -138.32M
Net Income -142.19M
EBITDA -133.26M
EBIT -133.53M
Earnings Per Share (EPS) -$2.00
Full Income Statement

Balance Sheet

The company has $578.87 million in cash and $27.11 million in debt, giving a net cash position of $551.76 million or $5.90 per share.

Cash & Cash Equivalents 578.87M
Total Debt 27.11M
Net Cash 551.76M
Net Cash Per Share $5.90
Equity / Book Value 536.31M
Book Value Per Share 5.74
Working Capital 563.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$129.19 million and capital expenditures -$4,000, giving a free cash flow of -$129.19 million.

Operating Cash Flow -129.19M
Capital Expenditures -4,000
Free Cash Flow -129.19M
FCF Per Share -$1.82
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

89bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -104.48%
Shareholder Yield -104.48%
Earnings Yield -13.43%
FCF Yield -12.21%
Dividend Details

Analyst Forecast

The average price target for 89bio is $28.83, which is 154.91% higher than the current price. The consensus rating is "Buy".

Price Target $28.83
Price Target Difference 154.91%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -12.77%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2